CA3005899A1 - Compositions and methods for modulating an immune response - Google Patents

Info

Publication number

CA3005899A1

CA3005899A1 CA3005899A CA3005899A CA3005899A1 CA 3005899 A1 CA3005899 A1 CA 3005899A1 CA 3005899 A CA3005899 A CA 3005899A CA 3005899 A CA3005899 A CA 3005899A CA 3005899 A1 CA3005899 A1 CA 3005899A1

Authority

CA

Canada

Prior art keywords

cells

tfr

tfh

cell

subject

Prior art date

2015-11-23

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 238000000034 method Methods 0.000 title claims abstract description 76
• 239000000203 mixture Substances 0.000 title claims description 100
• 230000028993 immune response Effects 0.000 title claims description 42
• 230000001629 suppression Effects 0.000 claims abstract description 143
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 78
• 201000010099 disease Diseases 0.000 claims abstract description 65
• 108010074108 interleukin-21 Proteins 0.000 claims abstract description 61
• 230000016784 immunoglobulin production Effects 0.000 claims abstract description 55
• 230000001717 pathogenic effect Effects 0.000 claims abstract description 28
• 206010028980 Neoplasm Diseases 0.000 claims abstract description 25
• 201000011510 cancer Diseases 0.000 claims abstract description 16
• 108010046926 intraovarian peptides Proteins 0.000 claims abstract description 12
• 206010017533 Fungal infection Diseases 0.000 claims abstract description 6
• 208000031888 Mycoses Diseases 0.000 claims abstract description 6
• 210000004027 cell Anatomy 0.000 claims description 610
• 239000003795 chemical substances by application Substances 0.000 claims description 97
• 230000005875 antibody response Effects 0.000 claims description 46
• 230000001404 mediated effect Effects 0.000 claims description 39
• 102000004127 Cytokines Human genes 0.000 claims description 37
• 108090000695 Cytokines Proteins 0.000 claims description 37
• 230000004936 stimulating effect Effects 0.000 claims description 28
• 210000005259 peripheral blood Anatomy 0.000 claims description 26
• 239000011886 peripheral blood Substances 0.000 claims description 26
• 230000001681 protective effect Effects 0.000 claims description 25
• 239000002671 adjuvant Substances 0.000 claims description 24
• 238000000338 in vitro Methods 0.000 claims description 24
• 230000001965 increasing effect Effects 0.000 claims description 21
• 229960005486 vaccine Drugs 0.000 claims description 21
• 108090001005 Interleukin-6 Proteins 0.000 claims description 15
• 230000000694 effects Effects 0.000 claims description 14
• 238000001727 in vivo Methods 0.000 claims description 13
• 230000005965 immune activity Effects 0.000 claims description 11
• 208000015181 infectious disease Diseases 0.000 claims description 11
• 230000008506 pathogenesis Effects 0.000 claims description 11
• 210000001519 tissue Anatomy 0.000 claims description 10
• 208000036142 Viral infection Diseases 0.000 claims description 9
• 230000007423 decrease Effects 0.000 claims description 9
• 230000002829 reductive effect Effects 0.000 claims description 9
• 230000001105 regulatory effect Effects 0.000 claims description 9
• 230000009385 viral infection Effects 0.000 claims description 9
• 210000000056 organ Anatomy 0.000 claims description 6
• 208000035143 Bacterial infection Diseases 0.000 claims description 5
• 208000022362 bacterial infectious disease Diseases 0.000 claims description 5
• 210000000130 stem cell Anatomy 0.000 claims description 5
• 230000021633 leukocyte mediated immunity Effects 0.000 abstract description 15
• 238000011282 treatment Methods 0.000 abstract description 14
• 230000001580 bacterial effect Effects 0.000 abstract description 4
• 230000003612 virological effect Effects 0.000 abstract description 3
• 210000003719 b-lymphocyte Anatomy 0.000 description 273
• 238000003556 assay Methods 0.000 description 78
• 108090000623 proteins and genes Proteins 0.000 description 71
• 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 description 59
• 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 59
• -1 CD45RB Proteins 0.000 description 57
• 102100030704 Interleukin-21 Human genes 0.000 description 55
• 102000005962 receptors Human genes 0.000 description 54
• 108020003175 receptors Proteins 0.000 description 54
• 230000014509 gene expression Effects 0.000 description 53
• 102100040678 Programmed cell death protein 1 Human genes 0.000 description 41
• 101710089372 Programmed cell death protein 1 Proteins 0.000 description 41
• 102100031658 C-X-C chemokine receptor type 5 Human genes 0.000 description 39
• 101000922405 Homo sapiens C-X-C chemokine receptor type 5 Proteins 0.000 description 39
• 241000699670 Mus sp. Species 0.000 description 39
• 239000000427 antigen Substances 0.000 description 32
• 108091007433 antigens Proteins 0.000 description 31
• 102000036639 antigens Human genes 0.000 description 31
• 210000004369 blood Anatomy 0.000 description 31
• 239000008280 blood Substances 0.000 description 31
• 230000037361 pathway Effects 0.000 description 28
• 230000006798 recombination Effects 0.000 description 28
• 238000005215 recombination Methods 0.000 description 28
• 230000004060 metabolic process Effects 0.000 description 25
• 230000004913 activation Effects 0.000 description 24
• 230000003915 cell function Effects 0.000 description 22
• 239000012636 effector Substances 0.000 description 22
• 210000003289 regulatory T cell Anatomy 0.000 description 22
• 239000005557 antagonist Substances 0.000 description 21
• 230000006870 function Effects 0.000 description 21
• 239000012228 culture supernatant Substances 0.000 description 19
• 230000034659 glycolysis Effects 0.000 description 19
• 230000037353 metabolic pathway Effects 0.000 description 19
• 238000003559 RNA-seq method Methods 0.000 description 18
• 210000001744 T-lymphocyte Anatomy 0.000 description 18
• 101000801234 Homo sapiens Tumor necrosis factor receptor superfamily member 18 Proteins 0.000 description 17
• 239000003446 ligand Substances 0.000 description 17
• 239000000556 agonist Substances 0.000 description 16
• 230000002503 metabolic effect Effects 0.000 description 16
• 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 15
• 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 15
• 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 15
• 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 15
• 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 description 15
• 230000003828 downregulation Effects 0.000 description 15
• 239000003550 marker Substances 0.000 description 15
• 230000035755 proliferation Effects 0.000 description 15
• 102100033728 Tumor necrosis factor receptor superfamily member 18 Human genes 0.000 description 14
• 230000000903 blocking effect Effects 0.000 description 14
• 230000002103 transcriptional effect Effects 0.000 description 14
• 208000035475 disorder Diseases 0.000 description 13
• 238000002255 vaccination Methods 0.000 description 13
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 12
• 238000004458 analytical method Methods 0.000 description 12
• 238000000684 flow cytometry Methods 0.000 description 12
• VRYALKFFQXWPIH-PBXRRBTRSA-N (3r,4s,5r)-3,4,5,6-tetrahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)CC=O VRYALKFFQXWPIH-PBXRRBTRSA-N 0.000 description 11
• 102000000844 Cell Surface Receptors Human genes 0.000 description 11
• 108010001857 Cell Surface Receptors Proteins 0.000 description 11
• 102000004190 Enzymes Human genes 0.000 description 11
• 108090000790 Enzymes Proteins 0.000 description 11
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 11
• PMMURAAUARKVCB-UHFFFAOYSA-N alpha-D-ara-dHexp Natural products OCC1OC(O)CC(O)C1O PMMURAAUARKVCB-UHFFFAOYSA-N 0.000 description 11
• 210000000987 immune system Anatomy 0.000 description 11
• 229960000485 methotrexate Drugs 0.000 description 11
• 238000010186 staining Methods 0.000 description 11
• 238000012360 testing method Methods 0.000 description 11
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
• 241000700605 Viruses Species 0.000 description 10
• 230000002950 deficient Effects 0.000 description 10
• 230000002401 inhibitory effect Effects 0.000 description 10
• 208000023275 Autoimmune disease Diseases 0.000 description 9
• 102100027207 CD27 antigen Human genes 0.000 description 9
• 101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 9
• 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 description 9
• 101001126417 Homo sapiens Platelet-derived growth factor receptor alpha Proteins 0.000 description 9
• 101000863883 Homo sapiens Sialic acid-binding Ig-like lectin 9 Proteins 0.000 description 9
• 101000633780 Homo sapiens Signaling lymphocytic activation molecule Proteins 0.000 description 9
• 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 9
• 102100030485 Platelet-derived growth factor receptor alpha Human genes 0.000 description 9
• 102100029965 Sialic acid-binding Ig-like lectin 9 Human genes 0.000 description 9
• 102100029215 Signaling lymphocytic activation molecule Human genes 0.000 description 9
• 230000003042 antagnostic effect Effects 0.000 description 9
• 230000001363 autoimmune Effects 0.000 description 9
• 230000003247 decreasing effect Effects 0.000 description 9
• 230000002708 enhancing effect Effects 0.000 description 9
• 238000002474 experimental method Methods 0.000 description 9
• 210000001280 germinal center Anatomy 0.000 description 9
• 239000003112 inhibitor Substances 0.000 description 9
• 230000001225 therapeutic effect Effects 0.000 description 9
• JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 8
• LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 8
• 229960002170 azathioprine Drugs 0.000 description 8
• 210000001165 lymph node Anatomy 0.000 description 8
• 238000004519 manufacturing process Methods 0.000 description 8
• 206010028417 myasthenia gravis Diseases 0.000 description 8
• 239000006228 supernatant Substances 0.000 description 8
• 201000000596 systemic lupus erythematosus Diseases 0.000 description 8
• LAQPKDLYOBZWBT-NYLDSJSYSA-N (2s,4s,5r,6r)-5-acetamido-2-{[(2s,3r,4s,5s,6r)-2-{[(2r,3r,4r,5r)-5-acetamido-1,2-dihydroxy-6-oxo-4-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-6-[(1r,2r)-1,2,3-trihydrox Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@@H](NC(C)=O)C=O)[C@@H]([C@H](O)CO)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 LAQPKDLYOBZWBT-NYLDSJSYSA-N 0.000 description 7
• 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 description 7
• 102100026423 Adhesion G protein-coupled receptor E5 Human genes 0.000 description 7
• 102100035248 Alpha-(1,3)-fucosyltransferase 4 Human genes 0.000 description 7
• 102100022749 Aminopeptidase N Human genes 0.000 description 7
• 102100024167 C-C chemokine receptor type 3 Human genes 0.000 description 7
• 102100036302 C-C chemokine receptor type 6 Human genes 0.000 description 7
• 102100024220 CD180 antigen Human genes 0.000 description 7
• 102100025222 CD63 antigen Human genes 0.000 description 7
• 108090000835 CX3C Chemokine Receptor 1 Proteins 0.000 description 7
• 102100039196 CX3C chemokine receptor 1 Human genes 0.000 description 7
• 102100024533 Carcinoembryonic antigen-related cell adhesion molecule 1 Human genes 0.000 description 7
• 102100023126 Cell surface glycoprotein MUC18 Human genes 0.000 description 7
• 102100030886 Complement receptor type 1 Human genes 0.000 description 7
• 238000002965 ELISA Methods 0.000 description 7
• 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 description 7
• 101000718243 Homo sapiens Adhesion G protein-coupled receptor E5 Proteins 0.000 description 7
• 101001022185 Homo sapiens Alpha-(1,3)-fucosyltransferase 4 Proteins 0.000 description 7
• 101000757160 Homo sapiens Aminopeptidase N Proteins 0.000 description 7
• 101000980744 Homo sapiens C-C chemokine receptor type 3 Proteins 0.000 description 7
• 101000716068 Homo sapiens C-C chemokine receptor type 6 Proteins 0.000 description 7
• 101000980829 Homo sapiens CD180 antigen Proteins 0.000 description 7
• 101000934368 Homo sapiens CD63 antigen Proteins 0.000 description 7
• 101000981093 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 1 Proteins 0.000 description 7
• 101000623903 Homo sapiens Cell surface glycoprotein MUC18 Proteins 0.000 description 7
• 101000727061 Homo sapiens Complement receptor type 1 Proteins 0.000 description 7
• 101000994378 Homo sapiens Integrin alpha-3 Proteins 0.000 description 7
• 101001015004 Homo sapiens Integrin beta-3 Proteins 0.000 description 7
• 101000599858 Homo sapiens Intercellular adhesion molecule 2 Proteins 0.000 description 7
• 101000599862 Homo sapiens Intercellular adhesion molecule 3 Proteins 0.000 description 7
• 101001001420 Homo sapiens Interferon gamma receptor 1 Proteins 0.000 description 7
• 101001083151 Homo sapiens Interleukin-10 receptor subunit alpha Proteins 0.000 description 7
• 101000961065 Homo sapiens Interleukin-18 receptor 1 Proteins 0.000 description 7
• 101000984196 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily A member 5 Proteins 0.000 description 7
• 101000984190 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily B member 1 Proteins 0.000 description 7
• 101000608935 Homo sapiens Leukosialin Proteins 0.000 description 7
• 101000917826 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-a Proteins 0.000 description 7
• 101000917824 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-b Proteins 0.000 description 7
• 101001063392 Homo sapiens Lymphocyte function-associated antigen 3 Proteins 0.000 description 7
• 101000873418 Homo sapiens P-selectin glycoprotein ligand 1 Proteins 0.000 description 7
• 101000863900 Homo sapiens Sialic acid-binding Ig-like lectin 5 Proteins 0.000 description 7
• 101000709256 Homo sapiens Signal-regulatory protein beta-1 Proteins 0.000 description 7
• 101000709188 Homo sapiens Signal-regulatory protein beta-1 isoform 3 Proteins 0.000 description 7
• 101000835093 Homo sapiens Transferrin receptor protein 1 Proteins 0.000 description 7
• 101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 description 7
• 102100032819 Integrin alpha-3 Human genes 0.000 description 7
• 102100032999 Integrin beta-3 Human genes 0.000 description 7
• 102100037872 Intercellular adhesion molecule 2 Human genes 0.000 description 7
• 102100037871 Intercellular adhesion molecule 3 Human genes 0.000 description 7
• 102100035678 Interferon gamma receptor 1 Human genes 0.000 description 7
• 102100030236 Interleukin-10 receptor subunit alpha Human genes 0.000 description 7
• 102100039340 Interleukin-18 receptor 1 Human genes 0.000 description 7
• 108090000978 Interleukin-4 Proteins 0.000 description 7
• 102000004388 Interleukin-4 Human genes 0.000 description 7
• 102100025574 Leukocyte immunoglobulin-like receptor subfamily A member 5 Human genes 0.000 description 7
• 102100039564 Leukosialin Human genes 0.000 description 7
• 102100029204 Low affinity immunoglobulin gamma Fc region receptor II-a Human genes 0.000 description 7
• 102100030984 Lymphocyte function-associated antigen 3 Human genes 0.000 description 7
• 102100034925 P-selectin glycoprotein ligand 1 Human genes 0.000 description 7
• 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 7
• 102100029957 Sialic acid-binding Ig-like lectin 5 Human genes 0.000 description 7
• 102100032770 Signal-regulatory protein beta-1 isoform 3 Human genes 0.000 description 7
• 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 description 7
• 102000013530 TOR Serine-Threonine Kinases Human genes 0.000 description 7
• 108091023040 Transcription factor Proteins 0.000 description 7
• 102100026144 Transferrin receptor protein 1 Human genes 0.000 description 7
• 102100040403 Tumor necrosis factor receptor superfamily member 6 Human genes 0.000 description 7
• 230000003213 activating effect Effects 0.000 description 7
• 230000002238 attenuated effect Effects 0.000 description 7
• 230000008827 biological function Effects 0.000 description 7
• 229910052799 carbon Inorganic materials 0.000 description 7
• 230000030833 cell death Effects 0.000 description 7
• 230000004049 epigenetic modification Effects 0.000 description 7
• 239000008103 glucose Substances 0.000 description 7
• 230000005764 inhibitory process Effects 0.000 description 7
• 230000004044 response Effects 0.000 description 7
• 230000011664 signaling Effects 0.000 description 7
• 230000000392 somatic effect Effects 0.000 description 7
• CCEKAJIANROZEO-UHFFFAOYSA-N sulfluramid Chemical group CCNS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F CCEKAJIANROZEO-UHFFFAOYSA-N 0.000 description 7
• 208000024891 symptom Diseases 0.000 description 7
• 230000003827 upregulation Effects 0.000 description 7
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 6
• 101710102159 Atrial natriuretic peptide receptor 2 Proteins 0.000 description 6
• 102100039341 Atrial natriuretic peptide receptor 2 Human genes 0.000 description 6
• 102100029822 B- and T-lymphocyte attenuator Human genes 0.000 description 6
• 102100037904 CD9 antigen Human genes 0.000 description 6
• 102100025470 Carcinoembryonic antigen-related cell adhesion molecule 8 Human genes 0.000 description 6
• 102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 description 6
• 102000006354 HLA-DR Antigens Human genes 0.000 description 6
• 108010058597 HLA-DR Antigens Proteins 0.000 description 6
• 108010024164 HLA-G Antigens Proteins 0.000 description 6
• 101000738354 Homo sapiens CD9 antigen Proteins 0.000 description 6
• 101000914320 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 8 Proteins 0.000 description 6
• 102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 description 6
• 102100023678 Killer cell lectin-like receptor subfamily B member 1 Human genes 0.000 description 6
• 102100027744 Semaphorin-4D Human genes 0.000 description 6
• 102100033447 T-lymphocyte surface antigen Ly-9 Human genes 0.000 description 6
• 102000040945 Transcription factor Human genes 0.000 description 6
• 210000000612 antigen-presenting cell Anatomy 0.000 description 6
• 238000006243 chemical reaction Methods 0.000 description 6
• 238000003501 co-culture Methods 0.000 description 6
• 229940120124 dichloroacetate Drugs 0.000 description 6
• JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 6
• 239000003814 drug Substances 0.000 description 6
• 230000003993 interaction Effects 0.000 description 6
• 201000006417 multiple sclerosis Diseases 0.000 description 6
• 230000010627 oxidative phosphorylation Effects 0.000 description 6
• 230000004144 purine metabolism Effects 0.000 description 6
• 230000028327 secretion Effects 0.000 description 6
• 208000009329 Graft vs Host Disease Diseases 0.000 description 5
• 206010025323 Lymphomas Diseases 0.000 description 5
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
• 102100025131 T-cell differentiation antigen CD6 Human genes 0.000 description 5
• 239000011324 bead Substances 0.000 description 5
• 230000008901 benefit Effects 0.000 description 5
• 230000019522 cellular metabolic process Effects 0.000 description 5
• 230000008859 change Effects 0.000 description 5
• 230000004069 differentiation Effects 0.000 description 5
• 239000003623 enhancer Substances 0.000 description 5
• 208000024908 graft versus host disease Diseases 0.000 description 5
• 238000000099 in vitro assay Methods 0.000 description 5
• 238000001802 infusion Methods 0.000 description 5
• 230000003834 intracellular effect Effects 0.000 description 5
• 230000002018 overexpression Effects 0.000 description 5
• 244000052769 pathogen Species 0.000 description 5
• ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 5
• QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 5
• 229960002930 sirolimus Drugs 0.000 description 5
• 150000003384 small molecules Chemical class 0.000 description 5
• 238000002560 therapeutic procedure Methods 0.000 description 5
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 4
• 230000003844 B-cell-activation Effects 0.000 description 4
• 108010077544 Chromatin Proteins 0.000 description 4
• 102000008186 Collagen Human genes 0.000 description 4
• 108010035532 Collagen Proteins 0.000 description 4
• 241000701022 Cytomegalovirus Species 0.000 description 4
• 108020004414 DNA Proteins 0.000 description 4
• 102100025137 Early activation antigen CD69 Human genes 0.000 description 4
• 206010018364 Glomerulonephritis Diseases 0.000 description 4
• 101000934374 Homo sapiens Early activation antigen CD69 Proteins 0.000 description 4
• 101001042104 Homo sapiens Inducible T-cell costimulator Proteins 0.000 description 4
• 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 description 4
• 101000934341 Homo sapiens T-cell surface glycoprotein CD5 Proteins 0.000 description 4
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 4
• 241000701044 Human gammaherpesvirus 4 Species 0.000 description 4
• 102100021317 Inducible T-cell costimulator Human genes 0.000 description 4
• 102100022338 Integrin alpha-M Human genes 0.000 description 4
• 241001529936 Murinae Species 0.000 description 4
• 241000699666 Mus <mouse, genus> Species 0.000 description 4
• 229940124160 Myc inhibitor Drugs 0.000 description 4
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 4
• 230000006044 T cell activation Effects 0.000 description 4
• 102100025244 T-cell surface glycoprotein CD5 Human genes 0.000 description 4
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 4
• 206010047115 Vasculitis Diseases 0.000 description 4
• 239000012190 activator Substances 0.000 description 4
• 230000007815 allergy Effects 0.000 description 4
• 238000010171 animal model Methods 0.000 description 4
• 230000000692 anti-sense effect Effects 0.000 description 4
• 230000009286 beneficial effect Effects 0.000 description 4
• 230000015572 biosynthetic process Effects 0.000 description 4
• 230000036755 cellular response Effects 0.000 description 4
• 210000003483 chromatin Anatomy 0.000 description 4
• 229920001436 collagen Polymers 0.000 description 4
• 238000010790 dilution Methods 0.000 description 4
• 239000012895 dilution Substances 0.000 description 4
• 230000004190 glucose uptake Effects 0.000 description 4
• 210000002443 helper t lymphocyte Anatomy 0.000 description 4
• 210000002865 immune cell Anatomy 0.000 description 4
• 230000003053 immunization Effects 0.000 description 4
• 238000009169 immunotherapy Methods 0.000 description 4
• 230000002438 mitochondrial effect Effects 0.000 description 4
• 230000000638 stimulation Effects 0.000 description 4
• XGWFJBFNAQHLEF-UHFFFAOYSA-N 9-anthroic acid Chemical compound C1=CC=C2C(C(=O)O)=C(C=CC=C3)C3=CC2=C1 XGWFJBFNAQHLEF-UHFFFAOYSA-N 0.000 description 3
• 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 3
• 241000193738 Bacillus anthracis Species 0.000 description 3
• 102100036301 C-C chemokine receptor type 7 Human genes 0.000 description 3
• 102100027217 CD82 antigen Human genes 0.000 description 3
• 102000024905 CD99 Human genes 0.000 description 3
• 108060001253 CD99 Proteins 0.000 description 3
• 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 3
• 208000015943 Coeliac disease Diseases 0.000 description 3
• 208000027932 Collagen disease Diseases 0.000 description 3
• 206010018693 Granuloma inguinale Diseases 0.000 description 3
• 208000015023 Graves' disease Diseases 0.000 description 3
• 101000914469 Homo sapiens CD82 antigen Proteins 0.000 description 3
• 101000878602 Homo sapiens Immunoglobulin alpha Fc receptor Proteins 0.000 description 3
• 101001023379 Homo sapiens Lysosome-associated membrane glycoprotein 1 Proteins 0.000 description 3
• 101000596234 Homo sapiens T-cell surface protein tactile Proteins 0.000 description 3
• 206010020751 Hypersensitivity Diseases 0.000 description 3
• 102100038005 Immunoglobulin alpha Fc receptor Human genes 0.000 description 3
• 102100035133 Lysosome-associated membrane glycoprotein 1 Human genes 0.000 description 3
• 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 3
• 241000700159 Rattus Species 0.000 description 3
• 102100039808 Receptor-type tyrosine-protein phosphatase eta Human genes 0.000 description 3
• 241000607142 Salmonella Species 0.000 description 3
• 206010039491 Sarcoma Diseases 0.000 description 3
• 102100035268 T-cell surface protein tactile Human genes 0.000 description 3
• 208000026935 allergic disease Diseases 0.000 description 3
• 206010003246 arthritis Diseases 0.000 description 3
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
• 230000032823 cell division Effects 0.000 description 3
• 230000004663 cell proliferation Effects 0.000 description 3
• 230000000875 corresponding effect Effects 0.000 description 3
• 230000000139 costimulatory effect Effects 0.000 description 3
• 230000016396 cytokine production Effects 0.000 description 3
• 210000004443 dendritic cell Anatomy 0.000 description 3
• 239000008121 dextrose Substances 0.000 description 3
• 230000003292 diminished effect Effects 0.000 description 3
• 229940079593 drug Drugs 0.000 description 3
• 210000003162 effector t lymphocyte Anatomy 0.000 description 3
• 239000002158 endotoxin Substances 0.000 description 3
• 230000008995 epigenetic change Effects 0.000 description 3
• 230000002496 gastric effect Effects 0.000 description 3
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
• 230000036737 immune function Effects 0.000 description 3
• 230000006028 immune-suppresssive effect Effects 0.000 description 3
• 238000005462 in vivo assay Methods 0.000 description 3
• 238000001990 intravenous administration Methods 0.000 description 3
• 229920006008 lipopolysaccharide Polymers 0.000 description 3
• 238000012986 modification Methods 0.000 description 3
• 201000005962 mycosis fungoides Diseases 0.000 description 3
• 208000008795 neuromyelitis optica Diseases 0.000 description 3
• 210000004180 plasmocyte Anatomy 0.000 description 3
• 230000003389 potentiating effect Effects 0.000 description 3
• 239000002243 precursor Substances 0.000 description 3
• 230000002265 prevention Effects 0.000 description 3
• 239000011780 sodium chloride Substances 0.000 description 3
• 230000004083 survival effect Effects 0.000 description 3
• 229940124597 therapeutic agent Drugs 0.000 description 3
• 238000012546 transfer Methods 0.000 description 3
• 238000011269 treatment regimen Methods 0.000 description 3
• 230000004102 tricarboxylic acid cycle Effects 0.000 description 3
• 238000011144 upstream manufacturing Methods 0.000 description 3
• GEWDNTWNSAZUDX-WQMVXFAESA-N (-)-methyl jasmonate Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-WQMVXFAESA-N 0.000 description 2
• QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 2
• WBLZUCOIBUDNBV-UHFFFAOYSA-N 3-nitropropanoic acid Chemical compound OC(=O)CC[N+]([O-])=O WBLZUCOIBUDNBV-UHFFFAOYSA-N 0.000 description 2
• CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 2
• 108020005176 AU Rich Elements Proteins 0.000 description 2
• 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 2
• 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 2
• 208000031261 Acute myeloid leukaemia Diseases 0.000 description 2
• 206010003827 Autoimmune hepatitis Diseases 0.000 description 2
• 108091008875 B cell receptors Proteins 0.000 description 2
• 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 2
• 206010004146 Basal cell carcinoma Diseases 0.000 description 2
• DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 2
• 208000003508 Botulism Diseases 0.000 description 2
• 208000003174 Brain Neoplasms Diseases 0.000 description 2
• 206010006500 Brucellosis Diseases 0.000 description 2
• 101100317454 Caenorhabditis elegans xbp-1 gene Proteins 0.000 description 2
• 241000589874 Campylobacter fetus Species 0.000 description 2
• 241000222122 Candida albicans Species 0.000 description 2
• 206010061041 Chlamydial infection Diseases 0.000 description 2
• 208000006344 Churg-Strauss Syndrome Diseases 0.000 description 2
• 241000193155 Clostridium botulinum Species 0.000 description 2
• 206010009944 Colon cancer Diseases 0.000 description 2
• 208000035473 Communicable disease Diseases 0.000 description 2
• IELOKBJPULMYRW-NJQVLOCASA-N D-alpha-Tocopheryl Acid Succinate Chemical compound OC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C IELOKBJPULMYRW-NJQVLOCASA-N 0.000 description 2
• AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
• 101100393884 Drosophila melanogaster Glut1 gene Proteins 0.000 description 2
• 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 description 2
• 208000018428 Eosinophilic granulomatosis with polyangiitis Diseases 0.000 description 2
• 241000588724 Escherichia coli Species 0.000 description 2
• 208000012468 Ewing sarcoma/peripheral primitive neuroectodermal tumor Diseases 0.000 description 2
• 208000003807 Graves Disease Diseases 0.000 description 2
• 208000030836 Hashimoto thyroiditis Diseases 0.000 description 2
• 241000711549 Hepacivirus C Species 0.000 description 2
• 102000003745 Hepatocyte Growth Factor Human genes 0.000 description 2
• 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 2
• 241000709721 Hepatovirus A Species 0.000 description 2
• 208000017604 Hodgkin disease Diseases 0.000 description 2
• 208000021519 Hodgkin lymphoma Diseases 0.000 description 2
• 208000010747 Hodgkins lymphoma Diseases 0.000 description 2
• 241000282412 Homo Species 0.000 description 2
• 101001018097 Homo sapiens L-selectin Proteins 0.000 description 2
• 101000934376 Homo sapiens T-cell differentiation antigen CD6 Proteins 0.000 description 2
• 101000831007 Homo sapiens T-cell immunoreceptor with Ig and ITIM domains Proteins 0.000 description 2
• 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 description 2
• 241000701806 Human papillomavirus Species 0.000 description 2
• 108010002350 Interleukin-2 Proteins 0.000 description 2
• 102000015696 Interleukins Human genes 0.000 description 2
• 108010063738 Interleukins Proteins 0.000 description 2
• 102100033467 L-selectin Human genes 0.000 description 2
• 241000222722 Leishmania <genus> Species 0.000 description 2
• 208000032514 Leukocytoclastic vasculitis Diseases 0.000 description 2
• 241000186779 Listeria monocytogenes Species 0.000 description 2
• 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 2
• 241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 2
• 241000124008 Mammalia Species 0.000 description 2
• 208000003445 Mouth Neoplasms Diseases 0.000 description 2
• 208000034578 Multiple myelomas Diseases 0.000 description 2
• 101100179469 Mus musculus Ighg2b gene Proteins 0.000 description 2
• 241000204031 Mycoplasma Species 0.000 description 2
• 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 2
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 2
• 208000007641 Pinealoma Diseases 0.000 description 2
• 206010035226 Plasma cell myeloma Diseases 0.000 description 2
• 241000224016 Plasmodium Species 0.000 description 2
• 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 2
• QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 2
• 201000000582 Retinoblastoma Diseases 0.000 description 2
• 235000004443 Ricinus communis Nutrition 0.000 description 2
• 240000000528 Ricinus communis Species 0.000 description 2
• 241000606651 Rickettsiales Species 0.000 description 2
• 241000714474 Rous sarcoma virus Species 0.000 description 2
• 101150058068 SLC2A1 gene Proteins 0.000 description 2
• 206010041067 Small cell lung cancer Diseases 0.000 description 2
• 241000191940 Staphylococcus Species 0.000 description 2
• 108091008874 T cell receptors Proteins 0.000 description 2
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 2
• 208000031673 T-Cell Cutaneous Lymphoma Diseases 0.000 description 2
• 102100024834 T-cell immunoreceptor with Ig and ITIM domains Human genes 0.000 description 2
• 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 description 2
• LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 2
• 208000034784 Tularaemia Diseases 0.000 description 2
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
• 241000700647 Variola virus Species 0.000 description 2
• 241000607626 Vibrio cholerae Species 0.000 description 2
• 208000016025 Waldenstroem macroglobulinemia Diseases 0.000 description 2
• 208000033559 Waldenström macroglobulinemia Diseases 0.000 description 2
• 241000607479 Yersinia pestis Species 0.000 description 2
• MIFGOLAMNLSLGH-QOKNQOGYSA-N Z-Val-Ala-Asp(OMe)-CH2F Chemical compound COC(=O)C[C@@H](C(=O)CF)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)OCC1=CC=CC=C1 MIFGOLAMNLSLGH-QOKNQOGYSA-N 0.000 description 2
• 230000009471 action Effects 0.000 description 2
• 230000009824 affinity maturation Effects 0.000 description 2
• 230000003367 anti-collagen effect Effects 0.000 description 2
• 238000013459 approach Methods 0.000 description 2
• 244000052616 bacterial pathogen Species 0.000 description 2
• QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 2
• 210000004556 brain Anatomy 0.000 description 2
• 239000000969 carrier Substances 0.000 description 2
• 230000024245 cell differentiation Effects 0.000 description 2
• 238000002659 cell therapy Methods 0.000 description 2
• 230000001413 cellular effect Effects 0.000 description 2
• 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 2
• 201000007241 cutaneous T cell lymphoma Diseases 0.000 description 2
• 230000007547 defect Effects 0.000 description 2
• 206010012601 diabetes mellitus Diseases 0.000 description 2
• 238000010586 diagram Methods 0.000 description 2
• 235000014113 dietary fatty acids Nutrition 0.000 description 2
• PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 2
• 230000002222 downregulating effect Effects 0.000 description 2
• 230000027721 electron transport chain Effects 0.000 description 2
• 230000006718 epigenetic regulation Effects 0.000 description 2
• 229930195729 fatty acid Natural products 0.000 description 2
• 239000000194 fatty acid Substances 0.000 description 2
• 150000004665 fatty acids Chemical class 0.000 description 2
• 239000012530 fluid Substances 0.000 description 2
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
• 230000003325 follicular Effects 0.000 description 2
• 150000002303 glucose derivatives Chemical class 0.000 description 2
• 230000002414 glycolytic effect Effects 0.000 description 2
• 201000009277 hairy cell leukemia Diseases 0.000 description 2
• 238000003306 harvesting Methods 0.000 description 2
• 244000000013 helminth Species 0.000 description 2
• 210000005260 human cell Anatomy 0.000 description 2
• 230000008629 immune suppression Effects 0.000 description 2
• 210000002602 induced regulatory T cell Anatomy 0.000 description 2
• 230000001939 inductive effect Effects 0.000 description 2
• 208000027866 inflammatory disease Diseases 0.000 description 2
• 230000002757 inflammatory effect Effects 0.000 description 2
• 206010022000 influenza Diseases 0.000 description 2
• 238000002347 injection Methods 0.000 description 2
• 239000007924 injection Substances 0.000 description 2
• 239000000543 intermediate Substances 0.000 description 2
• 210000003734 kidney Anatomy 0.000 description 2
• 208000032839 leukemia Diseases 0.000 description 2
• WDRYRZXSPDWGEB-UHFFFAOYSA-N lonidamine Chemical compound C12=CC=CC=C2C(C(=O)O)=NN1CC1=CC=C(Cl)C=C1Cl WDRYRZXSPDWGEB-UHFFFAOYSA-N 0.000 description 2
• 229960003538 lonidamine Drugs 0.000 description 2
• 206010025135 lupus erythematosus Diseases 0.000 description 2
• 210000004698 lymphocyte Anatomy 0.000 description 2
• 229940124302 mTOR inhibitor Drugs 0.000 description 2
• 210000002540 macrophage Anatomy 0.000 description 2
• 239000003628 mammalian target of rapamycin inhibitor Substances 0.000 description 2
• 238000005259 measurement Methods 0.000 description 2
• 201000001441 melanoma Diseases 0.000 description 2
• XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 2
• 229960003105 metformin Drugs 0.000 description 2
• GEWDNTWNSAZUDX-UHFFFAOYSA-N methyl 7-epi-jasmonate Natural products CCC=CCC1C(CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-UHFFFAOYSA-N 0.000 description 2
• 230000004048 modification Effects 0.000 description 2
• 230000035772 mutation Effects 0.000 description 2
• MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 2
• 208000002154 non-small cell lung carcinoma Diseases 0.000 description 2
• 201000008968 osteosarcoma Diseases 0.000 description 2
• 238000007254 oxidation reaction Methods 0.000 description 2
• 230000007170 pathology Effects 0.000 description 2
• 239000008194 pharmaceutical composition Substances 0.000 description 2
• 208000005987 polymyositis Diseases 0.000 description 2
• 208000025638 primary cutaneous T-cell non-Hodgkin lymphoma Diseases 0.000 description 2
• 208000029340 primitive neuroectodermal tumor Diseases 0.000 description 2
• 108090000765 processed proteins & peptides Proteins 0.000 description 2
• 238000012545 processing Methods 0.000 description 2
• 239000000047 product Substances 0.000 description 2
• 230000001737 promoting effect Effects 0.000 description 2
• 230000000069 prophylactic effect Effects 0.000 description 2
• 235000021283 resveratrol Nutrition 0.000 description 2
• 229940016667 resveratrol Drugs 0.000 description 2
• 230000000717 retained effect Effects 0.000 description 2
• 206010039073 rheumatoid arthritis Diseases 0.000 description 2
• 235000002020 sage Nutrition 0.000 description 2
• 238000000926 separation method Methods 0.000 description 2
• 210000002966 serum Anatomy 0.000 description 2
• 208000000587 small cell lung carcinoma Diseases 0.000 description 2
• 241000894007 species Species 0.000 description 2
• 210000002784 stomach Anatomy 0.000 description 2
• 239000000758 substrate Substances 0.000 description 2
• 201000008205 supratentorial primitive neuroectodermal tumor Diseases 0.000 description 2
• 239000000725 suspension Substances 0.000 description 2
• 230000002459 sustained effect Effects 0.000 description 2
• 208000008732 thymoma Diseases 0.000 description 2
• 206010043778 thyroiditis Diseases 0.000 description 2
• 230000014616 translation Effects 0.000 description 2
• 201000008827 tuberculosis Diseases 0.000 description 2
• 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 2
• 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 description 2
• 241001529453 unidentified herpesvirus Species 0.000 description 2
• 241001430294 unidentified retrovirus Species 0.000 description 2
• 229940118696 vibrio cholerae Drugs 0.000 description 2
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
• 102000010400 1-phosphatidylinositol-3-kinase activity proteins Human genes 0.000 description 1
• KISWVXRQTGLFGD-UHFFFAOYSA-N 2-[[2-[[6-amino-2-[[2-[[2-[[5-amino-2-[[2-[[1-[2-[[6-amino-2-[(2,5-diamino-5-oxopentanoyl)amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-(diaminomethylideneamino)p Chemical compound C1CCN(C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(N)CCC(N)=O)C1C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 KISWVXRQTGLFGD-UHFFFAOYSA-N 0.000 description 1
• MDJIPXYRSZHCFS-UHFFFAOYSA-N 2-phenyl-n-[5-[2-[2-[5-[(2-phenylacetyl)amino]-1,3,4-thiadiazol-2-yl]ethylsulfanyl]ethyl]-1,3,4-thiadiazol-2-yl]acetamide Chemical compound N=1N=C(CCSCCC=2SC(NC(=O)CC=3C=CC=CC=3)=NN=2)SC=1NC(=O)CC1=CC=CC=C1 MDJIPXYRSZHCFS-UHFFFAOYSA-N 0.000 description 1
• 101150050925 ATP5PB gene Proteins 0.000 description 1
• 101150113336 Acadm gene Proteins 0.000 description 1
• 241000606729 Actinobacillus equuli Species 0.000 description 1
• 241000256111 Aedes <genus> Species 0.000 description 1
• 229940126638 Akt inhibitor Drugs 0.000 description 1
• 208000032671 Allergic granulomatous angiitis Diseases 0.000 description 1
• 241000710929 Alphavirus Species 0.000 description 1
• 208000004881 Amebiasis Diseases 0.000 description 1
• 206010001935 American trypanosomiasis Diseases 0.000 description 1
• 206010001980 Amoebiasis Diseases 0.000 description 1
• 206010061424 Anal cancer Diseases 0.000 description 1
• 241000256186 Anopheles <genus> Species 0.000 description 1
• 208000003343 Antiphospholipid Syndrome Diseases 0.000 description 1
• 208000007860 Anus Neoplasms Diseases 0.000 description 1
• 206010073360 Appendix cancer Diseases 0.000 description 1
• 241000712891 Arenavirus Species 0.000 description 1
• 201000009695 Argentine hemorrhagic fever Diseases 0.000 description 1
• 201000002909 Aspergillosis Diseases 0.000 description 1
• 241000228212 Aspergillus Species 0.000 description 1
• 241001225321 Aspergillus fumigatus Species 0.000 description 1
• 208000036641 Aspergillus infections Diseases 0.000 description 1
• 206010003571 Astrocytoma Diseases 0.000 description 1
• 201000008271 Atypical teratoid rhabdoid tumor Diseases 0.000 description 1
• 238000012935 Averaging Methods 0.000 description 1
• 241000713826 Avian leukosis virus Species 0.000 description 1
• 108010074708 B7-H1 Antigen Proteins 0.000 description 1
• 208000004429 Bacillary Dysentery Diseases 0.000 description 1
• 241000894006 Bacteria Species 0.000 description 1
• 208000005440 Basal Cell Neoplasms Diseases 0.000 description 1
• 208000023328 Basedow disease Diseases 0.000 description 1
• 206010004593 Bile duct cancer Diseases 0.000 description 1
• 208000008439 Biliary Liver Cirrhosis Diseases 0.000 description 1
• 208000033222 Biliary cirrhosis primary Diseases 0.000 description 1
• 206010005003 Bladder cancer Diseases 0.000 description 1
• 206010005098 Blastomycosis Diseases 0.000 description 1
• 206010005949 Bone cancer Diseases 0.000 description 1
• 208000018084 Bone neoplasm Diseases 0.000 description 1
• 108030001720 Bontoxilysin Proteins 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 206010006143 Brain stem glioma Diseases 0.000 description 1
• 206010006187 Breast cancer Diseases 0.000 description 1
• 208000026310 Breast neoplasm Diseases 0.000 description 1
• 241000589562 Brucella Species 0.000 description 1
• 241000589567 Brucella abortus Species 0.000 description 1
• 241001509299 Brucella canis Species 0.000 description 1
• 241001148106 Brucella melitensis Species 0.000 description 1
• 241000589568 Brucella ovis Species 0.000 description 1
• 241001148111 Brucella suis Species 0.000 description 1
• 241000244036 Brugia Species 0.000 description 1
• 241000722910 Burkholderia mallei Species 0.000 description 1
• 206010069747 Burkholderia mallei infection Diseases 0.000 description 1
• 206010069748 Burkholderia pseudomallei infection Diseases 0.000 description 1
• 101710186200 CCAAT/enhancer-binding protein Proteins 0.000 description 1
• 102000049320 CD36 Human genes 0.000 description 1
• 108010045374 CD36 Antigens Proteins 0.000 description 1
• 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
• 206010007134 Candida infections Diseases 0.000 description 1
• 241000222178 Candida tropicalis Species 0.000 description 1
• 241000282472 Canis lupus familiaris Species 0.000 description 1
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
• 206010007279 Carcinoid tumour of the gastrointestinal tract Diseases 0.000 description 1
• 108010078791 Carrier Proteins Proteins 0.000 description 1
• 102000011727 Caspases Human genes 0.000 description 1
• 108010076667 Caspases Proteins 0.000 description 1
• 206010007953 Central nervous system lymphoma Diseases 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• 241000242722 Cestoda Species 0.000 description 1
• 208000024699 Chagas disease Diseases 0.000 description 1
• 108010008955 Chemokine CXCL13 Proteins 0.000 description 1
• 102000006574 Chemokine CXCL13 Human genes 0.000 description 1
• 201000009182 Chikungunya Diseases 0.000 description 1
• 241000606161 Chlamydia Species 0.000 description 1
• 241001647378 Chlamydia psittaci Species 0.000 description 1
• 206010008609 Cholangitis sclerosing Diseases 0.000 description 1
• 206010008631 Cholera Diseases 0.000 description 1
• 206010008803 Chromoblastomycosis Diseases 0.000 description 1
• 208000015116 Chromomycosis Diseases 0.000 description 1
• 241000669072 Chrysomphalus dictyospermi Species 0.000 description 1
• 241001112696 Clostridia Species 0.000 description 1
• 241000193468 Clostridium perfringens Species 0.000 description 1
• 241000193449 Clostridium tetani Species 0.000 description 1
• 241000224483 Coccidia Species 0.000 description 1
• 241000223205 Coccidioides immitis Species 0.000 description 1
• 102000000503 Collagen Type II Human genes 0.000 description 1
• 108010041390 Collagen Type II Proteins 0.000 description 1
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
• 241000711573 Coronaviridae Species 0.000 description 1
• 241001445332 Coxiella <snail> Species 0.000 description 1
• 208000009798 Craniopharyngioma Diseases 0.000 description 1
• 201000007336 Cryptococcosis Diseases 0.000 description 1
• 241001337994 Cryptococcus <scale insect> Species 0.000 description 1
• 241000221204 Cryptococcus neoformans Species 0.000 description 1
• 241000223936 Cryptosporidium parvum Species 0.000 description 1
• 208000016192 Demyelinating disease Diseases 0.000 description 1
• 208000001490 Dengue Diseases 0.000 description 1
• 206010012310 Dengue fever Diseases 0.000 description 1
• 206010012504 Dermatophytosis Diseases 0.000 description 1
• 241000243990 Dirofilaria Species 0.000 description 1
• 206010061818 Disease progression Diseases 0.000 description 1
• 208000030820 Ebola disease Diseases 0.000 description 1
• 241000588877 Eikenella Species 0.000 description 1
• 206010053025 Endemic syphilis Diseases 0.000 description 1
• 206010014733 Endometrial cancer Diseases 0.000 description 1
• 206010014759 Endometrial neoplasm Diseases 0.000 description 1
• 241000588921 Enterobacteriaceae Species 0.000 description 1
• 201000008228 Ependymoblastoma Diseases 0.000 description 1
• 206010014967 Ependymoma Diseases 0.000 description 1
• 206010014968 Ependymoma malignant Diseases 0.000 description 1
• 108050004280 Epsilon toxin Proteins 0.000 description 1
• 241000283086 Equidae Species 0.000 description 1
• 241000186810 Erysipelothrix rhusiopathiae Species 0.000 description 1
• 101000867232 Escherichia coli Heat-stable enterotoxin II Proteins 0.000 description 1
• 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
• 241000206602 Eukaryota Species 0.000 description 1
• 108700024394 Exon Proteins 0.000 description 1
• 208000009386 Experimental Arthritis Diseases 0.000 description 1
• 102000018711 Facilitative Glucose Transport Proteins Human genes 0.000 description 1
• 241000713800 Feline immunodeficiency virus Species 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 201000006353 Filariasis Diseases 0.000 description 1
• 241000711950 Filoviridae Species 0.000 description 1
• 241000589602 Francisella tularensis Species 0.000 description 1
• 241000233866 Fungi Species 0.000 description 1
• 108091006027 G proteins Proteins 0.000 description 1
• 102000030782 GTP binding Human genes 0.000 description 1
• 108091000058 GTP-Binding Proteins 0.000 description 1
• 208000022072 Gallbladder Neoplasms Diseases 0.000 description 1
• 241000207201 Gardnerella vaginalis Species 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• 208000021309 Germ cell tumor Diseases 0.000 description 1
• 201000003641 Glanders Diseases 0.000 description 1
• 208000032612 Glial tumor Diseases 0.000 description 1
• 206010018338 Glioma Diseases 0.000 description 1
• 108091052347 Glucose transporter family Proteins 0.000 description 1
• 208000024869 Goodpasture syndrome Diseases 0.000 description 1
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
• 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 description 1
• 208000031886 HIV Infections Diseases 0.000 description 1
• 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
• 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
• 241000700721 Hepatitis B virus Species 0.000 description 1
• 241000228402 Histoplasma Species 0.000 description 1
• 201000002563 Histoplasmosis Diseases 0.000 description 1
• 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 description 1
• 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 description 1
• 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 description 1
• 241000700588 Human alphaherpesvirus 1 Species 0.000 description 1
• 241000701074 Human alphaherpesvirus 2 Species 0.000 description 1
• 241000725303 Human immunodeficiency virus Species 0.000 description 1
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
• 241000713340 Human immunodeficiency virus 2 Species 0.000 description 1
• 206010020850 Hyperthyroidism Diseases 0.000 description 1
• 208000013038 Hypocalcemia Diseases 0.000 description 1
• 206010021042 Hypopharyngeal cancer Diseases 0.000 description 1
• 206010056305 Hypopharyngeal neoplasm Diseases 0.000 description 1
• 102000026633 IL6 Human genes 0.000 description 1
• 101150011508 Ighg1 gene Proteins 0.000 description 1
• 206010062016 Immunosuppression Diseases 0.000 description 1
• 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
• 206010022491 Insulin resistant diabetes Diseases 0.000 description 1
• 102000006992 Interferon-alpha Human genes 0.000 description 1
• 108010047761 Interferon-alpha Proteins 0.000 description 1
• 108090000176 Interleukin-13 Proteins 0.000 description 1
• 108090000172 Interleukin-15 Proteins 0.000 description 1
• 108010002586 Interleukin-7 Proteins 0.000 description 1
• 206010061252 Intraocular melanoma Diseases 0.000 description 1
• 208000009164 Islet Cell Adenoma Diseases 0.000 description 1
• 208000012528 Juvenile dermatomyositis Diseases 0.000 description 1
• 208000007766 Kaposi sarcoma Diseases 0.000 description 1
• 208000008839 Kidney Neoplasms Diseases 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
• 201000005099 Langerhans cell histiocytosis Diseases 0.000 description 1
• 206010023825 Laryngeal cancer Diseases 0.000 description 1
• 206010023927 Lassa fever Diseases 0.000 description 1
• 208000004554 Leishmaniasis Diseases 0.000 description 1
• 241000713666 Lentivirus Species 0.000 description 1
• 206010024229 Leprosy Diseases 0.000 description 1
• 241000589902 Leptospira Species 0.000 description 1
• 206010024238 Leptospirosis Diseases 0.000 description 1
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
• 208000034624 Leukocytoclastic Cutaneous Vasculitis Diseases 0.000 description 1
• 241000144128 Lichtheimia corymbifera Species 0.000 description 1
• 206010061523 Lip and/or oral cavity cancer Diseases 0.000 description 1
• 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 description 1
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
• 208000006644 Malignant Fibrous Histiocytoma Diseases 0.000 description 1
• 208000030070 Malignant epithelial tumor of ovary Diseases 0.000 description 1
• 208000032271 Malignant tumor of penis Diseases 0.000 description 1
• 208000000932 Marburg Virus Disease Diseases 0.000 description 1
• 201000011013 Marburg hemorrhagic fever Diseases 0.000 description 1
• 201000005505 Measles Diseases 0.000 description 1
• 102000009308 Mechanistic Target of Rapamycin Complex 2 Human genes 0.000 description 1
• 108010034057 Mechanistic Target of Rapamycin Complex 2 Proteins 0.000 description 1
• 208000000172 Medulloblastoma Diseases 0.000 description 1
• 206010027406 Mesothelioma Diseases 0.000 description 1
• 101150032582 Metap2 gene Proteins 0.000 description 1
• 206010027476 Metastases Diseases 0.000 description 1
• 241001460074 Microsporum distortum Species 0.000 description 1
• 241000713333 Mouse mammary tumor virus Species 0.000 description 1
• 101150097381 Mtor gene Proteins 0.000 description 1
• 101000687343 Mus musculus PR domain zinc finger protein 1 Proteins 0.000 description 1
• 101100407308 Mus musculus Pdcd1lg2 gene Proteins 0.000 description 1
• 241000041810 Mycetoma Species 0.000 description 1
• 241000186359 Mycobacterium Species 0.000 description 1
• 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
• 241000202955 Mycoplasma bovigenitalium Species 0.000 description 1
• 206010028470 Mycoplasma infections Diseases 0.000 description 1
• 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
• 102000047918 Myelin Basic Human genes 0.000 description 1
• 101710107068 Myelin basic protein Proteins 0.000 description 1
• 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 description 1
• 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
• 241000588653 Neisseria Species 0.000 description 1
• 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
• 241000244206 Nematoda Species 0.000 description 1
• 208000034176 Neoplasms, Germ Cell and Embryonal Diseases 0.000 description 1
• 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 description 1
• 206010029260 Neuroblastoma Diseases 0.000 description 1
• 241000526636 Nipah henipavirus Species 0.000 description 1
• 206010029443 Nocardia Infections Diseases 0.000 description 1
• 206010029444 Nocardiosis Diseases 0.000 description 1
• 244000020186 Nymphaea lutea Species 0.000 description 1
• 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
• 206010031096 Oropharyngeal cancer Diseases 0.000 description 1
• 206010057444 Oropharyngeal neoplasm Diseases 0.000 description 1
• 241000150452 Orthohantavirus Species 0.000 description 1
• 208000007571 Ovarian Epithelial Carcinoma Diseases 0.000 description 1
• 206010033128 Ovarian cancer Diseases 0.000 description 1
• 206010061328 Ovarian epithelial cancer Diseases 0.000 description 1
• 206010033268 Ovarian low malignant potential tumour Diseases 0.000 description 1
• 206010061535 Ovarian neoplasm Diseases 0.000 description 1
• 108091007960 PI3Ks Proteins 0.000 description 1
• 101150002582 PSPH gene Proteins 0.000 description 1
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
• 241000526686 Paracoccidioides brasiliensis Species 0.000 description 1
• 241000223785 Paramecium Species 0.000 description 1
• 208000000821 Parathyroid Neoplasms Diseases 0.000 description 1
• 241000606860 Pasteurella Species 0.000 description 1
• 201000011152 Pemphigus Diseases 0.000 description 1
• 208000002471 Penile Neoplasms Diseases 0.000 description 1
• 206010034299 Penile cancer Diseases 0.000 description 1
• 208000031845 Pernicious anaemia Diseases 0.000 description 1
• 241000710778 Pestivirus Species 0.000 description 1
• 208000009565 Pharyngeal Neoplasms Diseases 0.000 description 1
• 206010034811 Pharyngeal cancer Diseases 0.000 description 1
• 241000255129 Phlebotominae Species 0.000 description 1
• 240000009188 Phyllostachys vivax Species 0.000 description 1
• 206010050487 Pinealoblastoma Diseases 0.000 description 1
• 208000004842 Pinta Diseases 0.000 description 1
• 208000007913 Pituitary Neoplasms Diseases 0.000 description 1
• 206010035148 Plague Diseases 0.000 description 1
• 241000223960 Plasmodium falciparum Species 0.000 description 1
• 201000008199 Pleuropulmonary blastoma Diseases 0.000 description 1
• 241000233870 Pneumocystis Species 0.000 description 1
• 241000233872 Pneumocystis carinii Species 0.000 description 1
• 208000012654 Primary biliary cholangitis Diseases 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• 108700030875 Programmed Cell Death 1 Ligand 2 Proteins 0.000 description 1
• 102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 description 1
• 102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 description 1
• 206010060862 Prostate cancer Diseases 0.000 description 1
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
• 241000589516 Pseudomonas Species 0.000 description 1
• 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
• 206010037151 Psittacosis Diseases 0.000 description 1
• 201000004681 Psoriasis Diseases 0.000 description 1
• 206010037549 Purpura Diseases 0.000 description 1
• 241001672981 Purpura Species 0.000 description 1
• 206010037688 Q fever Diseases 0.000 description 1
• 241001506137 Rapa Species 0.000 description 1
• 208000015634 Rectal Neoplasms Diseases 0.000 description 1
• 241001124072 Reduviidae Species 0.000 description 1
• 206010038389 Renal cancer Diseases 0.000 description 1
• 241000158504 Rhodococcus hoagii Species 0.000 description 1
• 108010039491 Ricin Proteins 0.000 description 1
• 241000606701 Rickettsia Species 0.000 description 1
• 208000034712 Rickettsia Infections Diseases 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 238000011803 SJL/J (JAX™ mice strain) Methods 0.000 description 1
• 101150099493 STAT3 gene Proteins 0.000 description 1
• 208000004337 Salivary Gland Neoplasms Diseases 0.000 description 1
• 206010061934 Salivary gland cancer Diseases 0.000 description 1
• 241000607662 Salmonella enterica subsp. enterica serovar Abortusequi Species 0.000 description 1
• 241000522522 Salmonella enterica subsp. enterica serovar Abortusovis Species 0.000 description 1
• 241000242678 Schistosoma Species 0.000 description 1
• 206010039710 Scleroderma Diseases 0.000 description 1
• 102100023085 Serine/threonine-protein kinase mTOR Human genes 0.000 description 1
• 208000009359 Sezary Syndrome Diseases 0.000 description 1
• 208000021388 Sezary disease Diseases 0.000 description 1
• 241000607768 Shigella Species 0.000 description 1
• 241000607764 Shigella dysenteriae Species 0.000 description 1
• 206010040550 Shigella infections Diseases 0.000 description 1
• 208000021386 Sjogren Syndrome Diseases 0.000 description 1
• 208000000453 Skin Neoplasms Diseases 0.000 description 1
• 208000001203 Smallpox Diseases 0.000 description 1
• 208000021712 Soft tissue sarcoma Diseases 0.000 description 1
• 244000061456 Solanum tuberosum Species 0.000 description 1
• 235000002595 Solanum tuberosum Nutrition 0.000 description 1
• 206010041736 Sporotrichosis Diseases 0.000 description 1
• 241000295644 Staphylococcaceae Species 0.000 description 1
• 241001478880 Streptobacillus moniliformis Species 0.000 description 1
• 241000194017 Streptococcus Species 0.000 description 1
• 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
• 241000282887 Suidae Species 0.000 description 1
• 201000009594 Systemic Scleroderma Diseases 0.000 description 1
• 206010042953 Systemic sclerosis Diseases 0.000 description 1
• 230000005867 T cell response Effects 0.000 description 1
• 206010042971 T-cell lymphoma Diseases 0.000 description 1
• 208000027585 T-cell non-Hodgkin lymphoma Diseases 0.000 description 1
• 241000244155 Taenia Species 0.000 description 1
• 208000024313 Testicular Neoplasms Diseases 0.000 description 1
• 206010057644 Testis cancer Diseases 0.000 description 1
• 206010043376 Tetanus Diseases 0.000 description 1
• 206010043515 Throat cancer Diseases 0.000 description 1
• 201000009365 Thymic carcinoma Diseases 0.000 description 1
• 102000009843 Thyroglobulin Human genes 0.000 description 1
• 108010034949 Thyroglobulin Proteins 0.000 description 1
• 208000024770 Thyroid neoplasm Diseases 0.000 description 1
• 208000002474 Tinea Diseases 0.000 description 1
• 241000223996 Toxoplasma Species 0.000 description 1
• 241000223997 Toxoplasma gondii Species 0.000 description 1
• 201000005485 Toxoplasmosis Diseases 0.000 description 1
• 241000242541 Trematoda Species 0.000 description 1
• 241000869417 Trematodes Species 0.000 description 1
• 241000589884 Treponema pallidum Species 0.000 description 1
• 206010044608 Trichiniasis Diseases 0.000 description 1
• 241000224527 Trichomonas vaginalis Species 0.000 description 1
• 241001058196 Tritrichomonas foetus Species 0.000 description 1
• 241000186064 Trueperella pyogenes Species 0.000 description 1
• 241000223109 Trypanosoma cruzi Species 0.000 description 1
• 241000223089 Trypanosoma equiperdum Species 0.000 description 1
• 208000017379 Undifferentiated connective tissue syndrome Diseases 0.000 description 1
• 208000015778 Undifferentiated pleomorphic sarcoma Diseases 0.000 description 1
• 206010046431 Urethral cancer Diseases 0.000 description 1
• 206010046458 Urethral neoplasms Diseases 0.000 description 1
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• 208000002495 Uterine Neoplasms Diseases 0.000 description 1
• 201000005969 Uveal melanoma Diseases 0.000 description 1
• 206010047741 Vulval cancer Diseases 0.000 description 1
• 208000004354 Vulvar Neoplasms Diseases 0.000 description 1
• 241000710886 West Nile virus Species 0.000 description 1
• 208000005466 Western Equine Encephalomyelitis Diseases 0.000 description 1
• 201000005806 Western equine encephalitis Diseases 0.000 description 1
• 208000008383 Wilms tumor Diseases 0.000 description 1
• 208000003152 Yellow Fever Diseases 0.000 description 1
• 241000607734 Yersinia <bacteria> Species 0.000 description 1
• 241000907316 Zika virus Species 0.000 description 1
• 206010061418 Zygomycosis Diseases 0.000 description 1
• 230000001594 aberrant effect Effects 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 239000002253 acid Substances 0.000 description 1
• 201000007691 actinomycosis Diseases 0.000 description 1
• 230000003044 adaptive effect Effects 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 208000020990 adrenal cortex carcinoma Diseases 0.000 description 1
• 208000007128 adrenocortical carcinoma Diseases 0.000 description 1
• 229940009456 adriamycin Drugs 0.000 description 1
• 101150045355 akt1 gene Proteins 0.000 description 1
• 230000001476 alcoholic effect Effects 0.000 description 1
• 235000010443 alginic acid Nutrition 0.000 description 1
• 229920000615 alginic acid Polymers 0.000 description 1
• 230000003110 anti-inflammatory effect Effects 0.000 description 1
• 239000004599 antimicrobial Substances 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 235000006708 antioxidants Nutrition 0.000 description 1
• 201000011165 anus cancer Diseases 0.000 description 1
• 238000002617 apheresis Methods 0.000 description 1
• 230000006907 apoptotic process Effects 0.000 description 1
• 208000021780 appendiceal neoplasm Diseases 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 230000001174 ascending effect Effects 0.000 description 1
• 229940091771 aspergillus fumigatus Drugs 0.000 description 1
• 208000006673 asthma Diseases 0.000 description 1
• 210000001130 astrocyte Anatomy 0.000 description 1
• 230000005784 autoimmunity Effects 0.000 description 1
• 229940065181 bacillus anthracis Drugs 0.000 description 1
• 210000003651 basophil Anatomy 0.000 description 1
• 208000026900 bile duct neoplasm Diseases 0.000 description 1
• 230000008436 biogenesis Effects 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• 210000000988 bone and bone Anatomy 0.000 description 1
• 238000010322 bone marrow transplantation Methods 0.000 description 1
• 208000012172 borderline epithelial tumor of ovary Diseases 0.000 description 1
• 229940053031 botulinum toxin Drugs 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• 229940056450 brucella abortus Drugs 0.000 description 1
• 229940038698 brucella melitensis Drugs 0.000 description 1
• 229940074375 burkholderia mallei Drugs 0.000 description 1
• 239000006227 byproduct Substances 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• BPKIGYQJPYCAOW-FFJTTWKXSA-I calcium;potassium;disodium;(2s)-2-hydroxypropanoate;dichloride;dihydroxide;hydrate Chemical compound O.[OH-].[OH-].[Na+].[Na+].[Cl-].[Cl-].[K+].[Ca+2].C[C@H](O)C([O-])=O BPKIGYQJPYCAOW-FFJTTWKXSA-I 0.000 description 1
• 229940095731 candida albicans Drugs 0.000 description 1
• 201000003984 candidiasis Diseases 0.000 description 1
• 239000001768 carboxy methyl cellulose Substances 0.000 description 1
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 230000022131 cell cycle Effects 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 239000002771 cell marker Substances 0.000 description 1
• 238000001516 cell proliferation assay Methods 0.000 description 1
• 230000005889 cellular cytotoxicity Effects 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 201000004308 chancroid Diseases 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 239000002738 chelating agent Substances 0.000 description 1
• 239000003153 chemical reaction reagent Substances 0.000 description 1
• 201000010415 childhood type dermatomyositis Diseases 0.000 description 1
• 208000006990 cholangiocarcinoma Diseases 0.000 description 1
• 201000003486 coccidioidomycosis Diseases 0.000 description 1
• 208000029742 colonic neoplasm Diseases 0.000 description 1
• 230000002301 combined effect Effects 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 230000002596 correlated effect Effects 0.000 description 1
• 108091008034 costimulatory receptors Proteins 0.000 description 1
• 201000003740 cowpox Diseases 0.000 description 1
• 230000001351 cycling effect Effects 0.000 description 1
• 238000004163 cytometry Methods 0.000 description 1
• 230000001086 cytosolic effect Effects 0.000 description 1
• 231100000433 cytotoxic Toxicity 0.000 description 1
• 230000001472 cytotoxic effect Effects 0.000 description 1
• 208000025729 dengue disease Diseases 0.000 description 1
• 201000001981 dermatomyositis Diseases 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 230000018109 developmental process Effects 0.000 description 1
• 238000003745 diagnosis Methods 0.000 description 1
• 206010013023 diphtheria Diseases 0.000 description 1
• 230000005750 disease progression Effects 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• 239000003792 electrolyte Substances 0.000 description 1
• 208000014616 embryonal neoplasm Diseases 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 201000002491 encephalomyelitis Diseases 0.000 description 1
• 230000002124 endocrine Effects 0.000 description 1
• 210000004696 endometrium Anatomy 0.000 description 1
• 210000002889 endothelial cell Anatomy 0.000 description 1
• 210000003979 eosinophil Anatomy 0.000 description 1
• 201000004101 esophageal cancer Diseases 0.000 description 1
• 208000024519 eye neoplasm Diseases 0.000 description 1
• 230000004129 fatty acid metabolism Effects 0.000 description 1
• 208000001031 fetal erythroblastosis Diseases 0.000 description 1
• 210000002950 fibroblast Anatomy 0.000 description 1
• 235000013305 food Nutrition 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• 229940118764 francisella tularensis Drugs 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• 244000053095 fungal pathogen Species 0.000 description 1
• 201000010175 gallbladder cancer Diseases 0.000 description 1
• 201000011243 gastrointestinal stromal tumor Diseases 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 238000010199 gene set enrichment analysis Methods 0.000 description 1
• 230000004547 gene signature Effects 0.000 description 1
• 238000001415 gene therapy Methods 0.000 description 1
• 230000002068 genetic effect Effects 0.000 description 1
• 201000006592 giardiasis Diseases 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 210000003714 granulocyte Anatomy 0.000 description 1
• 230000012010 growth Effects 0.000 description 1
• 230000003394 haemopoietic effect Effects 0.000 description 1
• 201000010536 head and neck cancer Diseases 0.000 description 1
• 208000014829 head and neck neoplasm Diseases 0.000 description 1
• 210000002216 heart Anatomy 0.000 description 1
• 201000005787 hematologic cancer Diseases 0.000 description 1
• 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 1
• 230000002949 hemolytic effect Effects 0.000 description 1
• 208000005252 hepatitis A Diseases 0.000 description 1
• 210000003630 histaminocyte Anatomy 0.000 description 1
• 230000028996 humoral immune response Effects 0.000 description 1
• 230000004727 humoral immunity Effects 0.000 description 1
• 230000008348 humoral response Effects 0.000 description 1
• 201000006362 hypersensitivity vasculitis Diseases 0.000 description 1
• 230000000705 hypocalcaemia Effects 0.000 description 1
• 201000006866 hypopharynx cancer Diseases 0.000 description 1
• 230000002519 immonomodulatory effect Effects 0.000 description 1
• 230000003832 immune regulation Effects 0.000 description 1
• 230000036039 immunity Effects 0.000 description 1
• 230000005847 immunogenicity Effects 0.000 description 1
• 230000001506 immunosuppresive effect Effects 0.000 description 1
• 238000002650 immunosuppressive therapy Methods 0.000 description 1
• 230000001024 immunotherapeutic effect Effects 0.000 description 1
• 230000002637 immunotoxin Effects 0.000 description 1
• 239000002596 immunotoxin Substances 0.000 description 1
• 231100000608 immunotoxin Toxicity 0.000 description 1
• 229940051026 immunotoxin Drugs 0.000 description 1
• 230000006872 improvement Effects 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 239000011261 inert gas Substances 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 102000008640 interleukin-21 receptor activity proteins Human genes 0.000 description 1
• 108040002099 interleukin-21 receptor activity proteins Proteins 0.000 description 1
• 229940047122 interleukins Drugs 0.000 description 1
• 230000000968 intestinal effect Effects 0.000 description 1
• 210000004153 islets of langerhan Anatomy 0.000 description 1
• 210000002510 keratinocyte Anatomy 0.000 description 1
• 201000010982 kidney cancer Diseases 0.000 description 1
• 150000003893 lactate salts Chemical class 0.000 description 1
• 210000001821 langerhans cell Anatomy 0.000 description 1
• 206010023841 laryngeal neoplasm Diseases 0.000 description 1
• 230000002045 lasting effect Effects 0.000 description 1
• 210000000265 leukocyte Anatomy 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 201000007270 liver cancer Diseases 0.000 description 1
• 208000019423 liver disease Diseases 0.000 description 1
• 208000014018 liver neoplasm Diseases 0.000 description 1
• 244000144972 livestock Species 0.000 description 1
• 230000005923 long-lasting effect Effects 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• 201000005202 lung cancer Diseases 0.000 description 1
• 208000020816 lung neoplasm Diseases 0.000 description 1
• 208000001581 lymphogranuloma venereum Diseases 0.000 description 1
• 210000003563 lymphoid tissue Anatomy 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 201000004792 malaria Diseases 0.000 description 1
• 230000003211 malignant effect Effects 0.000 description 1
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
• 208000026045 malignant tumor of parathyroid gland Diseases 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 201000008203 medulloepithelioma Diseases 0.000 description 1
• 201000004015 melioidosis Diseases 0.000 description 1
• 238000001000 micrograph Methods 0.000 description 1
• 210000003470 mitochondria Anatomy 0.000 description 1
• 210000001616 monocyte Anatomy 0.000 description 1
• 201000000626 mucocutaneous leishmaniasis Diseases 0.000 description 1
• 201000007524 mucormycosis Diseases 0.000 description 1
• 201000009671 multidrug-resistant tuberculosis Diseases 0.000 description 1
• 210000000066 myeloid cell Anatomy 0.000 description 1
• 208000025113 myeloid leukemia Diseases 0.000 description 1
• 210000000822 natural killer cell Anatomy 0.000 description 1
• 210000002501 natural regulatory T cell Anatomy 0.000 description 1
• 201000008026 nephroblastoma Diseases 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 201000008106 ocular cancer Diseases 0.000 description 1
• 201000002575 ocular melanoma Diseases 0.000 description 1
• 210000004248 oligodendroglia Anatomy 0.000 description 1
• 201000000901 ornithosis Diseases 0.000 description 1
• 201000006958 oropharynx cancer Diseases 0.000 description 1
• 208000021284 ovarian germ cell tumor Diseases 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 201000002528 pancreatic cancer Diseases 0.000 description 1
• 208000008443 pancreatic carcinoma Diseases 0.000 description 1
• 208000022102 pancreatic neuroendocrine neoplasm Diseases 0.000 description 1
• 208000003154 papilloma Diseases 0.000 description 1
• 208000029211 papillomatosis Diseases 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• 201000001976 pemphigus vulgaris Diseases 0.000 description 1
• 230000009984 peri-natal effect Effects 0.000 description 1
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
• 201000003113 pineoblastoma Diseases 0.000 description 1
• 208000011079 pinta disease Diseases 0.000 description 1
• 208000010916 pituitary tumor Diseases 0.000 description 1
• 208000010626 plasma cell neoplasm Diseases 0.000 description 1
• 229920003023 plastic Polymers 0.000 description 1
• 239000004033 plastic Substances 0.000 description 1
• 201000000317 pneumocystosis Diseases 0.000 description 1
• 201000006292 polyarteritis nodosa Diseases 0.000 description 1
• 229920001184 polypeptide Polymers 0.000 description 1
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 208000016800 primary central nervous system lymphoma Diseases 0.000 description 1
• 230000037452 priming Effects 0.000 description 1
• 230000008569 process Effects 0.000 description 1
• 102000004196 processed proteins & peptides Human genes 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 230000012846 protein folding Effects 0.000 description 1
• 239000003197 protein kinase B inhibitor Substances 0.000 description 1
• 238000001243 protein synthesis Methods 0.000 description 1
• 102000004169 proteins and genes Human genes 0.000 description 1
• 230000002685 pulmonary effect Effects 0.000 description 1
• 230000006825 purine synthesis Effects 0.000 description 1
• 238000011002 quantification Methods 0.000 description 1
• 230000007420 reactivation Effects 0.000 description 1
• 230000009257 reactivity Effects 0.000 description 1
• 206010038038 rectal cancer Diseases 0.000 description 1
• 201000001275 rectum cancer Diseases 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• 230000012121 regulation of immune response Effects 0.000 description 1
• 238000007634 remodeling Methods 0.000 description 1
• 230000008672 reprogramming Effects 0.000 description 1
• 230000004043 responsiveness Effects 0.000 description 1
• 201000009410 rhabdomyosarcoma Diseases 0.000 description 1
• 201000003068 rheumatic fever Diseases 0.000 description 1
• 201000004409 schistosomiasis Diseases 0.000 description 1
• 208000010157 sclerosing cholangitis Diseases 0.000 description 1
• 210000005212 secondary lymphoid organ Anatomy 0.000 description 1
• 238000004062 sedimentation Methods 0.000 description 1
• 230000001235 sensitizing effect Effects 0.000 description 1
• 238000012163 sequencing technique Methods 0.000 description 1
• 206010040400 serum sickness Diseases 0.000 description 1
• 229940007046 shigella dysenteriae Drugs 0.000 description 1
• 201000005113 shigellosis Diseases 0.000 description 1
• 210000003491 skin Anatomy 0.000 description 1
• 201000000849 skin cancer Diseases 0.000 description 1
• 201000002314 small intestine cancer Diseases 0.000 description 1
• 239000007790 solid phase Substances 0.000 description 1
• 239000000243 solution Substances 0.000 description 1
• 238000001228 spectrum Methods 0.000 description 1
• 206010062261 spinal cord neoplasm Diseases 0.000 description 1
• 206010041823 squamous cell carcinoma Diseases 0.000 description 1
• 230000006641 stabilisation Effects 0.000 description 1
• 238000011105 stabilization Methods 0.000 description 1
• 238000012289 standard assay Methods 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 238000003860 storage Methods 0.000 description 1
• 210000002536 stromal cell Anatomy 0.000 description 1
• 239000000126 substance Substances 0.000 description 1
• 208000006379 syphilis Diseases 0.000 description 1
• 230000008685 targeting Effects 0.000 description 1
• 201000003120 testicular cancer Diseases 0.000 description 1
• 239000002562 thickening agent Substances 0.000 description 1
• 210000001541 thymus gland Anatomy 0.000 description 1
• 229960002175 thyroglobulin Drugs 0.000 description 1
• 201000002510 thyroid cancer Diseases 0.000 description 1
• 210000001685 thyroid gland Anatomy 0.000 description 1
• 238000002287 time-lapse microscopy Methods 0.000 description 1
• 238000011222 transcriptome analysis Methods 0.000 description 1
• 230000001052 transient effect Effects 0.000 description 1
• 238000013519 translation Methods 0.000 description 1
• 238000002054 transplantation Methods 0.000 description 1
• 230000032258 transport Effects 0.000 description 1
• 208000003982 trichinellosis Diseases 0.000 description 1
• 201000007588 trichinosis Diseases 0.000 description 1
• 201000002311 trypanosomiasis Diseases 0.000 description 1
• 230000004906 unfolded protein response Effects 0.000 description 1
• 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
• 241000712461 unidentified influenza virus Species 0.000 description 1
• 201000005112 urinary bladder cancer Diseases 0.000 description 1
• 206010046766 uterine cancer Diseases 0.000 description 1
• 208000037965 uterine sarcoma Diseases 0.000 description 1
• 210000004291 uterus Anatomy 0.000 description 1
• 206010046885 vaginal cancer Diseases 0.000 description 1
• 208000013139 vaginal neoplasm Diseases 0.000 description 1
• 201000006266 variola major Diseases 0.000 description 1
• 239000013598 vector Substances 0.000 description 1
• 201000005102 vulva cancer Diseases 0.000 description 1
• 201000009482 yaws Diseases 0.000 description 1